AMAG Pharma (AMAG) Posts Q2 Loss of $0.40

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. BROS
4. EXPE
5. ARM
6. QCOM
7. CPAY
8. DDOG
9. CHYM
10. PAYC

Go back to AMAG Pharma (AMAG) Posts Q2 Loss of $0.40

AMAG Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update

August 3, 2017 7:02 AM EDT

Second quarter 2017 GAAP revenue increased 24% over same period last year

 IntrarosaTM (prasterone) now commercially available

 Completed Feraheme® (ferumoxytol) submission to FDA to broaden label beyond chronic kidney disease

 Conference call scheduled for 8:00 a.m. ET today

WALTHAM, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the quarter ended June 30, 2017. Total GAAP revenue for the second quarter of 2017 increased to a record $158.4 million, 24% higher than the same period... More